Zarxio 300 mcg/0.5 mL PFS NDC 14 days supply
Published May 16, 2018 · Recall initiated: April 3, 2018
Summary
FDA records drug Class II recall D-0796-2018, published May 16, 2018 and initiated April 3, 2018. Recalling firm: Kroger Specialty Pharmacy, Inc.; Status: Terminated; Reported quantity: Unknown; Lot: All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Processing Controls.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Kroger Specialty Pharmacy, Inc.
- Distributor
- MS, LA, AR, IL, FL
- Lot
- All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAGleevec 100 mg tablet NDC 00078-0401-34 30 days supplyMay 16, 2018
- FDAOrkambi 100 mg/125 mg Tablets #112 NDC 51167-0700-02 28 days supply.May 16, 2018
- FDACopaxone 20 mg Injection PFS (30) NDC 68546-0317-30 30 days supply.May 16, 2018
- FDARevlimid 20 mg oral cap NDC 59572-0420-21 28 days supplyMay 16, 2018
- FDAPerjeta 420 mg/14 mL SDV Vials 50242-0145-01 21 days supplyMay 16, 2018
- FDATasigna Capsules 150 mg NDC 00078-0592-87 28 days supplyMay 16, 2018
Questions about this recall
Was Zarxio 300 mcg/0.5 mL PFS NDC 14 days supply recalled?
Yes. FDA published recall D-0796-2018 on May 16, 2018. Reported hazard: Lack of Processing Controls.
What should I do if I have this product?
Voluntary: Firm initiated · Letter